DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 145 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,437,360 | -30.6% | 113,000 | -23.1% | 0.01% | -33.3% |
| Q2 2023 | $2,069,760 | +59.5% | 147,000 | +75.0% | 0.01% | +28.6% |
| Q1 2023 | $1,297,800 | -10.0% | 84,000 | -4.5% | 0.01% | 0.0% |
| Q4 2022 | $1,442,320 | -50.7% | 88,000 | -44.3% | 0.01% | -50.0% |
| Q3 2022 | $2,923,000 | +40.7% | 158,000 | 0.0% | 0.01% | +55.6% |
| Q2 2022 | $2,078,000 | +647.5% | 158,000 | +426.7% | 0.01% | +800.0% |
| Q1 2022 | $278,000 | -96.1% | 30,000 | -75.0% | 0.00% | -98.2% |
| Q2 2020 | $7,154,000 | – | 119,800 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |